ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ABT Abbott Laboratories

100.00
-5.96 (-5.62%)
27 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Abbott Laboratories NYSE:ABT NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -5.96 -5.62% 100.00 107.14 104.66 106.78 8,610,056 01:00:00

Form 3 - Initial statement of beneficial ownership of securities

06/09/2023 11:48pm

Edgar (US Regulatory)


 

EX. 24

 

POWER OF ATTORNEY

 

The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA H. PAIK, and AARON N. RICE, and each of them individually, as the undersigned’s true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned’s name, place and stead, to prepare, sign, and file with the Securities and Exchange Commission (“SEC”) any and all forms and documents required under federal securities laws, including Rule 144 of the Securities Act of 1933, as amended, and Section 16(a) of the Securities Exchange Act of 1934, as amended, a Form ID and any other documents necessary to obtain codes, passphrases and passwords necessary to make electronic filings, and any other documents in connection therewith, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

 

A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to make filings under Rule 144 and Section 16(a) or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact.

 

Date: July 24, 2023

  /s/ John A. McCoy, Jr.
  Signature of Reporting Person
   
  John A. McCoy, Jr.
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064

 

 

 


1 Year Abbott Laboratories Chart

1 Year Abbott Laboratories Chart

1 Month Abbott Laboratories Chart

1 Month Abbott Laboratories Chart

Your Recent History

Delayed Upgrade Clock